FDA Adverse Event Injury Summary report: N

TAPER SLEEVE ADAPTER 12/14 +2

MDR report key: 3100485 · Received May 8, 2013

Report

Report Number
1818910-2013-05596
Event Type
Injury
Date Received
May 8, 2013
Date of Event
January 5, 2010
Report Date
October 2, 2014
Manufacturer
DEPUY INTERNATIONAL LTD. 8010379
Product Code
KWA
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED. THE CORRECTION/REMOVAL REPORTING NUMBER LISTED APPLIES TO THE CORRESPONDING PRODUCT CODE SOLD DOMESTICALLY.

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. DEPUY STILL CONSIDERS THIS CASE CLOSED TO CAPA.

Description of Event or Problem · 1

ASR REVISION; ASR RESURFACING - LEFT HIP; REASON FOR REVISION: UNKNOWN.

Description of Event or Problem · 1

NEW ETQ RECORD CREATED IN ORDER TO UPDATE ETQ (LEGACY SYSTEM) COMPLAINT NUMBER (B)(4). REASON FOR ORIGINAL COMPLAINT- ASR REVISION, ASR RESURFACING - LEFT, REASON(S) FOR REVISION: UNKNOWN. (B)(6). INVALID LOT NUMBER PROVIDED FOR STEM - (B)(4). UPDATE RECEIVED (B)(6) 2014. REVISION REASONS ADDED. LOT NUMBERS ADDED FOR HEAD AND CUP. ADDITIONAL HOSPITAL ADDED. REASON(S) FOR REVISION: ALVAL / SOFT TISSUE REACTION, PAIN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
201240 TAPER SLEEVE ADAPTER 12/14 +2 HIP FEMORAL STEM/SLEEVE KWA DEPUY INTERNATIONAL LTD. 8010379 2378970

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention